BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim YJ, Kim BK, Park SJ, Kim JH. Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells. World J Gastroenterol 2021; 27(29): 4879-4889 [PMID: 34447232 DOI: 10.3748/wjg.v27.i29.4879]
URL: https://www.wjgnet.com/1007-9327/full/v27/i29/4879.htm
Number Citing Articles
1
Ying Zhang, Xiaohan Xiang, Shaolan Zhou, Duygu Altinok Dindar, Stephanie Wood, Zhenzhen Zhang, Baoen Shan, Lianmei Zhao. Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative reviewExpert Review of Gastroenterology & Hepatology 2023; 17(4): 353 doi: 10.1080/17474124.2023.2189099
2
Ritis K. Shyanti, Jazmyn Greggs, Shalie Malik, Manoj Mishra. Gut dysbiosis impacts the immune system and promotes prostate cancerImmunology Letters 2024; 268: 106883 doi: 10.1016/j.imlet.2024.106883
3
Sarra B. Shakartalla, Tasneem M. Elsayed, Fatimah Almsailem, Fatma Almousa, Aseel Aldaihani, Sameh S. M. Soliman. Metabolic Dynamics in Host-Microbe Interaction2025; : 411 doi: 10.1007/978-981-96-1305-2_16
4
Ke Pu, Ting Luo, Juan Li, Qian Tang, Yang Feng, Guodong Yang. Periodontitis and gastrointestinal cancer: a nationwide cohort study of NHANES 2009–2014BMC Public Health 2025; 25(1) doi: 10.1186/s12889-025-21832-2
5
Xiaoyan Duan, Ping Chen, Xiaoxia Xu, Meiling Han, Jianbo Li, Stefania Cantore. Role of Gastric Microorganisms Other than Helicobacter pylori in the Development and Treatment of Gastric DiseasesBioMed Research International 2022; 2022(1) doi: 10.1155/2022/6263423
6
Alexa Little, Mark Tangney, Michael M. Tunney, Niamh E. Buckley. Fusobacterium nucleatum: a novel immune modulator in breast cancer?Expert Reviews in Molecular Medicine 2023; 25 doi: 10.1017/erm.2023.9
7
Qi Song, Zhiliang Jin, Han Zhang, Kunqiao Hong, Beibei Zhu, Haisen Yin, Baoping Yu. Fusobacterium nucleatum-derived 3-indolepropionic acid promotes colorectal cancer progression via aryl hydrocarbon receptor activation in macrophagesChemico-Biological Interactions 2025; 414: 111495 doi: 10.1016/j.cbi.2025.111495
8
Hongzhi He, Yu Hao, Yu Fan, Bolei Li, Lei Cheng. The interaction between innate immunity and oral microbiota in oral diseasesExpert Review of Clinical Immunology 2023; 19(4): 405 doi: 10.1080/1744666X.2023.2182291
9
Haixia Wang, Juanjuan Han, Xin-An Zhang. Interplay of m6A RNA methylation and gut microbiota in modulating gut injuryGut Microbes 2025; 17(1) doi: 10.1080/19490976.2025.2467213
10
María Belén Novoa Díaz, María Julia Martín, Claudia Gentili. Tumor microenvironment involvement in colorectal cancer progression <i>via</i> Wnt/β-catenin pathway: Providing understanding of the complex mechanisms of chemoresistanceWorld Journal of Gastroenterology 2022; 28(26): 3027-3046 doi: 10.3748/wjg.v28.i26.3027
11
Suwen Ou, Hufei Wang, Yangbao Tao, Kangjia Luo, Jinhua Ye, Songlin Ran, Zilong Guan, Yuliuming Wang, Hanqing Hu, Rui Huang. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanismFrontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.1020583
12
Tomasz M. Karpiński, Marcin Ożarowski, Mark Stasiewicz. Carcinogenic microbiota and its role in colorectal cancer developmentSeminars in Cancer Biology 2022; 86: 420 doi: 10.1016/j.semcancer.2022.01.004
13
Qing Gu, Jiaqian Yan, Yeqing Lou, Zihao Zhang, Yonglu Li, Zichun Zhu, Manman Liu, Danli Wu, Ying Liang, Jiaqian Pu, Xiaodan Zhao, Hang Xiao, Ping Li. Bacteriocins: Curial guardians of gastrointestinal tractComprehensive Reviews in Food Science and Food Safety 2024; 23(1) doi: 10.1111/1541-4337.13292
14
Jing Li, Ai-hua Zhang, Fang-fang Wu, Xi-jun Wang. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future ProspectsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.841552
15
Bo Han, Yongfeng Zhang, Xue Feng, Jun Yang, Baolin Wang, Jiang Fang, Zhigang Wang, Jun Zhu, Ge Niu, Youxiang Guo. The power of microbes: the key role of gut microbiota in the initiation and progression of colorectal cancerFrontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1563886
16
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalisFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
17
Rongrong Li, Jilu Shen, Yuanhong Xu. Fusobacterium nucleatum and Colorectal CancerInfection and Drug Resistance 2022; : 1115 doi: 10.2147/IDR.S357922
18
Dustin L. Higashi, Madeline C. Krieger, Hua Qin, Zhengzhong Zou, Elizabeth A. Palmer, Jens Kreth, Justin Merritt. Who is in the driver's seat? Parvimonas micra: An understudied pathobiont at the crossroads of dysbiotic disease and cancerEnvironmental Microbiology Reports 2023; 15(4): 254 doi: 10.1111/1758-2229.13153
19
En-Hua Mei, Chao Yao, Yi-Nan Chen, Shun-Xue Nan, Sheng-Cai Qi. Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2024; 16(5): 688-702 doi: 10.4254/wjh.v16.i5.688
20
Sima Ataollahi Eshkoor, Sara Fanijavadi. Dysbiosis–epigenetics–immune system interaction and ageing health problems Journal of Medical Microbiology 2024; 73(11) doi: 10.1099/jmm.0.001921
21
Ho Yin Pekkle Lam, Meng-Jiun Lai, Pin-Chun Wang, Wen-Jui Wu, Li-Kuang Chen, Hsiang-Wei Fan, Chun-Chieh Tseng, Shih-Yi Peng, Kai-Chih Chang. A Novel Bacteriophage with the Potential to Inhibit Fusobacterium nucleatum-Induced Proliferation of Colorectal Cancer CellsAntibiotics 2025; 14(1): 45 doi: 10.3390/antibiotics14010045
22
Jialing Liu, Jiyang Jiang, Yue Lan, Chengyan Li, Ruiying Han, Jiao Wang, Tianyi Wang, Zhihe Zhao, Zhenxin Fan, Libang He, Jie Fang. Metagenomic analysis of oral and intestinal microbiome of patients during the initial stage of orthodontic treatmentAmerican Journal of Orthodontics and Dentofacial Orthopedics 2024; 165(2): 161 doi: 10.1016/j.ajodo.2023.07.019